Besides, the impact of ITGA7 on survival profiles of NSCLC patients was evaluated in our study, which observed that patients with ITGA7 high expression achieved poorer survival profiles compared with patients with ITGA7 low expression. This evidence concerns the gene ITGA7 and non-small cell lung carcinoma.